高级检索
当前位置: 首页 > 详情页

An ultrasound-guided no incision banding method for the treatment of arteriovenous fistula high-flow in hemodialysis

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

单位: [1]Department of Nephrology, Tongji Hospital of Tongji medical college of Huazhong University of Science and Technology, Wuhan, China. [2]Department of Hematology and Nephropathy, Xishui People's Hospital, Huanggang City, China.
出处:
ISSN:

关键词: Arteriovenous fistula high-flow vascular access no-incision banding method hemodialysis

摘要:
High-flow vascular access is one of the serious complications in the maturation and subsequent use of arteriovenous fistula (AVF). We adopted a novel surgical approach named no incision limited ligation indwelling needle assisted- revision (NILLINR) to treat high-flow of the hemodialysis vascular access and ascertained the outcomes by regular follow-up visits.This is a retrospective study. 26 hemodialysis patients with symptomatic high-flow access (access flow > 1500 mL/min) were treated with the novel banding method without incision between June 2018 and October 2020. The flow of the brachial artery before and after the restriction was measured by experienced clinicians by using the duplex Doppler ultrasound (DUS). All 26 patients were followed up for up to 1 year. Meanwhile, the brachial artery flow was recorded at 6 months and 1 year after restriction.Of all 26 patients included in this study, the mean access flow volume decreased from 2196.2 ± 416.9 mL/min (mean ± SD) to 679.2 ± 67.1 mL/min immediately after the operation. During the follow-up, the volume flow of the brachial artery was still within the restricted range at 6 months (mean ± SD, 720.2 ± 164.7 mL/min) and 1 year (mean ± SD, 713.9 ± 173.8 mL/min) after the operation. Meanwhile, the mean duration of the operation is 8.5 ± 3.3 min, and there is no bleeding or rupture.This novel no-incision limited ligation indwelling needle-assisted revision is a safe, effective, and time-saving option to treat high-flow access.

基金:
语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2022]版:
大类 | 3 区 医学
小类 | 3 区 泌尿学与肾脏学
最新[2025]版:
大类 | 3 区 医学
小类 | 3 区 泌尿学与肾脏学
JCR分区:
出版当年[2021]版:
Q2 UROLOGY & NEPHROLOGY
最新[2024]版:
Q1 UROLOGY & NEPHROLOGY

影响因子: 最新[2024版] 最新五年平均 出版当年[2021版] 出版当年五年平均 出版前一年[2020版] 出版后一年[2022版]

第一作者:
第一作者单位: [1]Department of Nephrology, Tongji Hospital of Tongji medical college of Huazhong University of Science and Technology, Wuhan, China.
共同第一作者:
通讯作者:
通讯机构: [1]Department of Nephrology, Tongji Hospital of Tongji medical college of Huazhong University of Science and Technology, Wuhan, China. [*1]Department of Nephrology, Tongji Hospital of Tongji medical college of Huazhong University of Science and Technology, Jiefang Avenue. 1095, 430030, Wuhan, Hubei Province, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:622 今日访问量:4 总访问量:456 更新日期:2025-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)